Suppr超能文献

在骨骼畸形患者中进行双重分子诊断的描述。

Delineation of dual molecular diagnosis in patients with skeletal deformity.

机构信息

Department of Orthopedic Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Beijing, 100730, China.

Graduate School of Peking Union Medical College, Beijing, 100730, China.

出版信息

Orphanet J Rare Dis. 2022 Mar 28;17(1):139. doi: 10.1186/s13023-022-02293-x.

Abstract

BACKGROUND

Skeletal deformity is characterized by an abnormal anatomical structure of bone and cartilage. In our previous studies, we have found that a substantial proportion of patients with skeletal deformity could be explained by monogenic disorders. More recently, complex phenotypes caused by more than one genetic defect (i.e., dual molecular diagnosis) have also been reported in skeletal deformities and may complicate the diagnostic odyssey of patients. In this study, we report the molecular and phenotypic characteristics of patients with dual molecular diagnosis and variable skeletal deformities.

RESULTS

From 1108 patients who underwent exome sequencing, we identified eight probands with dual molecular diagnosis and variable skeletal deformities. All eight patients had dual diagnosis consisting of two autosomal dominant diseases. A total of 16 variants in 12 genes were identified, 5 of which were of de novo origin. Patients with dual molecular diagnosis presented blended phenotypes of two genetic diseases. Mendelian disorders occurred more than once include Osteogenesis Imperfecta Type I (COL1A1, MIM:166200), Neurofibromatosis, Type I (NF1, MIM:162200) and Marfan Syndrome (FBN1, MIM:154700).

CONCLUSIONS

This study demonstrated the complicated skeletal phenotypes associated with dual molecular diagnosis. Exome sequencing represents a powerful tool to detect such complex conditions.

摘要

背景

骨骼畸形的特征是骨骼和软骨的解剖结构异常。在我们之前的研究中,我们发现相当一部分骨骼畸形患者可以用单基因疾病来解释。最近,骨骼畸形也有报道称存在由一个以上遗传缺陷引起的复杂表型(即双重分子诊断),这可能会使患者的诊断变得更加复杂。在这项研究中,我们报告了具有双重分子诊断和可变骨骼畸形的患者的分子和表型特征。

结果

从接受外显子组测序的 1108 名患者中,我们确定了 8 名具有双重分子诊断和可变骨骼畸形的先证者。所有 8 例患者均为双诊断,包括两种常染色体显性疾病。共鉴定出 12 个基因中的 16 个变异,其中 5 个为新生变异。具有双重分子诊断的患者表现出两种遗传疾病的混合表型。多次发生的孟德尔疾病包括 I 型成骨不全症(COL1A1,MIM:166200)、I 型神经纤维瘤病(NF1,MIM:162200)和马凡综合征(FBN1,MIM:154700)。

结论

本研究表明,双重分子诊断与复杂的骨骼表型有关。外显子组测序是检测此类复杂疾病的有力工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f0d/8962553/3516e4f1edc2/13023_2022_2293_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验